TREXIMET (Formerly Known as TREXIMA) for the Acute Treatment of Probable Migraine (ICHD-II 1.6.1)

NCT00387881 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

679

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine, Without Aura

Interventions

DRUG: sumatriptan succinate / naproxen sodium
DRUG: Placebo

Sponsor

GlaxoSmithKline